UNIGE document Scientific Article
previous document  unige:155542  next document
add to browser collection
Title

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Authors
Zaballa, María-Eugenia
Perez-Saez, Javier
Pullen, Nick
de Mestral, Carlos
Pennacchio, Francesco
show hidden authors show all authors [1 - 22]
Collaboration
Published in The Lancet Infectious Diseases. 2021, vol. 21, no. 5, p. 600-601
Keywords AdolescentAdultAgedAged, 80 and overCOVID-19/diagnosis/epidemiologyCOVID-19 Serological TestingChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedSARS-CoV-2/immunologySeroepidemiologic StudiesYoung Adult
Identifiers
PMID: 33539733
Full text
Article (Published version) (76 Kb) - public document Free access
Appendix (342 Kb) - public document Free access
Other version: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063076/
Structures
Research groups Groupe Laurent Kaiser (virologie clinique) (668)
Emerging viruses (993)
Médecine de 1er recours (1020)
Recherche en infectiologie pédiatrique et en pédiatrie générale (853)
Groupe Flahault Antoine (945)
Chimie et protéomique clinique (270)
Staphylocoques dorés résistants à la méthicilline et hygiène hospitalière (330)
Citation
(ISO format)
STRINGHINI, Silvia et al. Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak. In: The Lancet Infectious Diseases, 2021, vol. 21, n° 5, p. 600-601. doi: 10.1016/S1473-3099(21)00054-2 https://archive-ouverte.unige.ch/unige:155542

22 hits

12 downloads

Update

Deposited on : 2021-10-20

Export document
Format :
Citation style :